Cargando…

Platelet activation and hypercoagulability in patients with early primary biliary cholangitis compared with healthy controls

BACKGROUND: Patients with primary biliary cholangitis (PBC) who have advanced disease are hypercoagulable, with no thrombophilic factors compared to non-cholestatic cirrhotics. We investigated whether hypercoagulability is present in early-stage PBC. METHODS: PBC patients with biopsy-documented earl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vlachogiannakos, Jiannis, Binas, Jiannis, Siakavellas, Spyros, Karagiannakis, Dimitrios S., Voulgaris, Theodoros, Papatheodoridis, George V., Ladas, Spiros D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hellenic Society of Gastroenterology 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903578/ https://www.ncbi.nlm.nih.gov/pubmed/33654364 http://dx.doi.org/10.20524/aog.2021.0572

Ejemplares similares

Prevalence of cirrhotic cardiomyopathy according to different diagnostic criteria: alterations in ultrasonographic parameters of both left and right ventricles before and after stress
por: Karagiannakis, Dimitrios S., et al.
Publicado: (2023)

Systemic levels of human β-defensin 1 are elevated in patients with cirrhosis
por: Kaltsa, Garyfallia, et al.
Publicado: (2016)

High prevalence of asymptomatic peptic ulcers diagnosed during screening endoscopy in patients with cirrhosis
por: Voulgaris, Theodoros, et al.
Publicado: (2019)

The Lyon Consensus Criteria for GERD Diagnosis in a Greek Population: The Clinical Impact and Changes in GERD Diagnosis in a Real-World, Retrospective Study
por: Voulgaris, Theodoros, et al.
Publicado: (2022)

Efficacy of citalopram or amitriptyline versus no treatment in patients with functional chest pain
por: Voulgaris, Theodoros, et al.
Publicado: (2023)

Serum zonulin levels in patients with liver cirrhosis: Prognostic implications
por: Voulgaris, Theodoros A, et al.
Publicado: (2021)

Elevated Serum Levels of the Antiapoptotic Protein Decoy-Receptor 3 Are Associated with Advanced Liver Disease
por: Bamias, Giorgos, et al.
Publicado: (2016)

Ursodeoxycholic Acid Improves Bilirubin but Not Albumin in Primary Biliary Cirrhosis: Further Evidence for Nonefficacy
por: Tsochatzis, Emmanuel A., et al.
Publicado: (2013)

Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis
por: Sarcognato, Samantha, et al.
Publicado: (2021)

Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease
por: Kostas, Athanasios, et al.
Publicado: (2017)

Osteoporosis in primary biliary cholangitis
por: Danford, Christopher J, et al.
Publicado: (2018)

Baricitinib and primary biliary cholangitis
por: Gordon, Stuart C., et al.
Publicado: (2021)

Role of autoantibodies in the clinical management of primary biliary cholangitis
por: Rigopoulou, Eirini I, et al.
Publicado: (2023)

Overlap Syndrome between Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
por: Sundaram, Sridhar, et al.
Publicado: (2018)

Evaluation of the United Kingdom‐primary biliary cholangitis and global primary biliary cholangitis group prognostic models for primary biliary cholangitis patients treated with ursodeoxycholic acid in the U.S. population
por: Alomari, Mohammad, et al.
Publicado: (2019)

Extrahepatic Manifestations of Primary Biliary Cholangitis
por: Chalifoux, Sara L, et al.
Publicado: (2017)

Obeticholic acid for primary biliary cholangitis
Publicado: (2020)

Current understanding of primary biliary cholangitis
por: Tanaka, Atsushi
Publicado: (2021)

Primary biliary cholangitis: pathogenic mechanisms
por: Prieto, Jesús, et al.
Publicado: (2021)

The Role of Epigenetics in Primary Biliary Cholangitis
por: Gerussi, Alessio, et al.
Publicado: (2022)

Obeticholic Acid for Primary Biliary Cholangitis
por: Floreani, Annarosa, et al.
Publicado: (2022)

Risk Stratification in Primary Biliary Cholangitis
por: Martini, Francesco, et al.
Publicado: (2023)

Predicting Risk in Primary Biliary Cholangitis
por: Cho, Eun Ju
Publicado: (2023)

Prediction of hepatocellular carcinoma development by aminotransferase to platelet ratio index in primary biliary cholangitis
por: Cheung, Ka-Shing, et al.
Publicado: (2017)

Platelet count to spleen thickness ratio is related to histologic severity of primary biliary cholangitis
por: Wang, Zhongfeng, et al.
Publicado: (2018)

Follicular T Helper Cell Signatures in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
por: Adam, Leonie, et al.
Publicado: (2018)

Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: Current Knowledge of Pathogenesis and Therapeutics
por: Park, Ji-Won, et al.
Publicado: (2022)

Possible Strongyloides stercoralis infection diagnosed by videocapsule endoscopy in an immunocompetent patient with devastating diarrhea
por: Xouris, Dimitrios, et al.
Publicado: (2012)

Clinical application of the GLOBE and United Kingdom‐primary biliary cholangitis risk scores in a trial cohort of patients with primary biliary cholangitis
por: Carbone, Marco, et al.
Publicado: (2018)

Atypical Mycobacterial Infection Presenting as Persistent Skin Lesion in a Patient with Ulcerative Colitis
por: Bamias, Giorgos, et al.
Publicado: (2011)

Overlap syndrome of primary biliary cholangitis and primary sclerosing cholangitis: two case reports
por: Yacoub, Haythem, et al.
Publicado: (2023)

Biomarkers for primary biliary cholangitis: current perspectives
por: Kouroumalis, Elias, et al.
Publicado: (2018)

Genetic Contribution to the Pathogenesis of Primary Biliary Cholangitis
por: Joshita, Satoru, et al.
Publicado: (2017)

New treatments/targets for primary biliary cholangitis
por: Corpechot, Christophe, et al.
Publicado: (2019)

Primary Biliary Cholangitis-associated Palmar Keratosis
por: Usami, Jun
Publicado: (2021)

Primary Biliary Cholangitis: A Case of Underdiagnosis
por: Garcês Soares, Sofia, et al.
Publicado: (2021)

Update on the Pharmacological Treatment of Primary Biliary Cholangitis
por: Floreani, Annarosa, et al.
Publicado: (2022)

Primary biliary cholangitis: Epidemiology, prognosis, and treatment
por: Trivella, Juan, et al.
Publicado: (2023)

Sequence of events leading to primary biliary cholangitis
por: Lenci, Ilaria, et al.
Publicado: (2023)

External validation of the United Kingdom‐primary biliary cholangitis risk scores of patients with primary biliary cholangitis treated with ursodeoxycholic acid
por: Cheung, Angela C., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_sptc5qh29n5jiv18j45a6kp1ai